Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Larsen

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Leukemia|November 16, 2019
Randomized assessment of delayed intensification and two methods for parenteral methotrexate delivery in childhood B-ALL: Children's Oncology Group Studies P9904 and P9905Naomi Winick, Paul L Martin, Meenakshi Devidas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2017
Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology GroupKristina K Hardy, Leanne Embry, John A Kairalla, et al.
Haematologica|April 21, 2019
Impact of corticosteroid pretreatment in pediatric patients with newly diagnosed B-lymphoblastic leukemia: a report from the Children's Oncology GroupElizabeth A Raetz, Mignon L Loh, Meenakshi Devidas, et al.
Leukemia & Lymphoma|November 9, 2017
Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children's oncology group (COG) clinical trialsMichael J Burke, Meenakshi Devidas, Kelly Maloney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2017
Reply to I.J. CohenKristina K Hardy, Leanne M Embry, John A Kairalla, et al.
Blood|December 30, 2017
Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALLBrent Wood, David Wu, Beryl Crossley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2017
Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology GroupNaomi Winick, Meenakshi Devidas, Si Chen, et al.
Research Square|July 28, 2023
Germline Genetic <i>NBN</i> Variation and Predisposition to B-cell Acute Lymphoblastic Leukemia in ChildrenCarolin Escherich, Wenan Chen, Yizhen Li, et al.
Blood|March 6, 2024
Germ line genetic NBN variation and predisposition to B-cell acute lymphoblastic leukemia in childrenCarolin S Escherich, Wenan Chen, Yizhen Li, et al.
Blood Advances|December 28, 2022
Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemiaCarolin Escherich, Wenan Chen, Satoshi Miyamoto, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Leukemia|November 16, 2019
Randomized assessment of delayed intensification and two methods for parenteral methotrexate delivery in childhood B-ALL: Children's Oncology Group Studies P9904 and P9905Naomi Winick, Paul L Martin, Meenakshi Devidas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2017
Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology GroupKristina K Hardy, Leanne Embry, John A Kairalla, et al.
Haematologica|April 21, 2019
Impact of corticosteroid pretreatment in pediatric patients with newly diagnosed B-lymphoblastic leukemia: a report from the Children's Oncology GroupElizabeth A Raetz, Mignon L Loh, Meenakshi Devidas, et al.
Leukemia & Lymphoma|November 9, 2017
Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children's oncology group (COG) clinical trialsMichael J Burke, Meenakshi Devidas, Kelly Maloney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2017
Reply to I.J. CohenKristina K Hardy, Leanne M Embry, John A Kairalla, et al.
Blood|December 30, 2017
Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALLBrent Wood, David Wu, Beryl Crossley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2017
Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology GroupNaomi Winick, Meenakshi Devidas, Si Chen, et al.
Research Square|July 28, 2023
Germline Genetic <i>NBN</i> Variation and Predisposition to B-cell Acute Lymphoblastic Leukemia in ChildrenCarolin Escherich, Wenan Chen, Yizhen Li, et al.
Blood|March 6, 2024
Germ line genetic NBN variation and predisposition to B-cell acute lymphoblastic leukemia in childrenCarolin S Escherich, Wenan Chen, Yizhen Li, et al.
Blood Advances|December 28, 2022
Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemiaCarolin Escherich, Wenan Chen, Satoshi Miyamoto, et al.
Pageof 5